欢迎来到麦多课文档分享! | 帮助中心 海量文档,免费浏览,给你所需,享你所想!
麦多课文档分享
全部分类
  • 标准规范>
  • 教学课件>
  • 考试资料>
  • 办公文档>
  • 学术论文>
  • 行业资料>
  • 易语言源码>
  • ImageVerifierCode 换一换
    首页 麦多课文档分享 > 资源分类 > PDF文档下载
    分享到微信 分享到微博 分享到QQ空间

    ANSI AAMI 5840-3-2013 Cardiovascular implants - Cardiac valve prostheses - Part 3 Heart valve substitutes implanted by transcatheter techniques.pdf

    • 资源ID:430341       资源大小:1.24MB        全文页数:128页
    • 资源格式: PDF        下载积分:10000积分
    快捷下载 游客一键下载
    账号登录下载
    微信登录下载
    二维码
    微信扫一扫登录
    下载资源需要10000积分(如需开发票,请勿充值!)
    邮箱/手机:
    温馨提示:
    如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
    如需开发票,请勿充值!如填写123,账号就是123,密码也是123。
    支付方式: 支付宝扫码支付    微信扫码支付   
    验证码:   换一换

    加入VIP,交流精品资源
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    ANSI AAMI 5840-3-2013 Cardiovascular implants - Cardiac valve prostheses - Part 3 Heart valve substitutes implanted by transcatheter techniques.pdf

    1、ANSI/AAMI/ISO 5840-3: 2013Cardiovascular implants Cardiac valve prostheses Part 3: Heart valve substitutes implanted by transcatheter techniquesAmerican National StandardObjectives and uses of AAMI standards and recommended practices It is most important that the objectives and potential uses of an

    2、AAMI product standard or recommended practice are clearly understood. The objectives of AAMIs technical development program derive from AAMIs overall mission: the advancement of medical instrumentation. Essential to such advancement are (1) a continued increase in the safe and effective application

    3、of current technologies to patient care, and (2) the encouragement of new technologies. It is AAMIs view that standards and recommended practices can contribute significantly to the advancement of medical instrumentation, provided that they are drafted with attention to these objectives and provided

    4、 that arbitrary and restrictive uses are avoided. A voluntary standard for a medical device recommends to the manufacturer the information that should be provided with or on the product, basic safety and performance criteria that should be considered in qualifying the device for clinical use, and th

    5、e measurement techniques that can be used to determine whether the device conforms with the safety and performance criteria and/or to compare the performance characteristics of different products. Some standards emphasize the information that should be provided with the device, including performance

    6、 characteristics, instructions for use, warnings and precautions, and other data considered important in ensuring the safe and effective use of the device in the clinical environment. Recommending the disclosure of performance characteristics often necessitates the development of specialized test me

    7、thods to facilitate uniformity in reporting; reaching consensus on these tests can represent a considerable part of committee work. When a drafting committee determines that clinical concerns warrant the establishment of minimum safety and performance criteria, referee tests must be provided and the

    8、 reasons for establishing the criteria must be documented in the rationale. A recommended practice provides guidelines for the use, care, and/or processing of a medical device or system. A recommended practice does not address device performance per se, but rather procedures and practices that will

    9、help ensure that a device is used safely and effectively and that its performance will be maintained. Although a device standard is primarily directed to the manufacturer, it may also be of value to the potential purchaser or user of the device as a frame of reference for device evaluation. Similarl

    10、y, even though a recommended practice is usually oriented towards healthcare professionals, it may be useful to the manufacturer in better understanding the environment in which a medical device will be used. Also, some recommended practices, while not addressing device performance criteria, provide

    11、 guidelines to industrial personnel on such subjects as sterilization processing, methods of collecting data to establish safety and efficacy, human engineering, and other processing or evaluation techniques; such guidelines may be useful to health care professionals in understanding industrial prac

    12、tices. In determining whether an AAMI standard or recommended practice is relevant to the specific needs of a potential user of the document, several important concepts must be recognized: All AAMI standards and recommended practices are voluntary (unless, of course, they are adopted by government r

    13、egulatory or procurement authorities). The application of a standard or recommended practice is solely within the discretion and professional judgment of the user of the document. Each AAMI standard or recommended practice reflects the collective expertise of a committee of health care professionals

    14、 and industrial representatives, whose work has been reviewed nationally (and sometimes internationally). As such, the consensus recommendations embodied in a standard or recommended practice are intended to respond to clinical needs and, ultimately, to help ensure patient safety. A standard or reco

    15、mmended practice is limited, however, in the sense that it responds generally to perceived risks and conditions that may not always be relevant to specific situations. A standard or recommended practice is an important reference in responsible decision-making, but it should never replace responsible

    16、 decision-making. Despite periodic review and revision (at least once every five years), a standard or recommended practice is necessarily a static document applied to a dynamic technology. Therefore, a standards user must carefully review the reasons why the document was initially developed and the

    17、 specific rationale for each of its provisions. This review will reveal whether the document remains relevant to the specific needs of the user. Particular care should be taken in applying a product standard to existing devices and equipment, and in applying a recommended practice to current procedu

    18、res and practices. While observed or potential risks with existing equipment typically form the basis for the safety and performance criteria defined in a standard, professional judgment must be used in applying these criteria to existing equipment. No single source of information will serve to iden

    19、tify a particular product as “unsafe“. A voluntary standard can be used as one resource, but the ultimate decision as to product safety and efficacy must take into account the specifics of its utilization and, of course, cost-benefit considerations. Similarly, a recommended practice should be analyz

    20、ed in the context of the specific needs and resources of the individual institution or firm. Again, the rationale accompanying each AAMI standard and recommended practice is an excellent guide to the reasoning and data underlying its provision. In summary, a standard or recommended practice is truly

    21、 useful only when it is used in conjunction with other sources of information and policy guidance and in the context of professional experience and judgment. INTERPRETATIONS OF AAMI STANDARDS AND RECOMMENDED PRACTICES Requests for interpretations of AAMI standards and recommended practices must be m

    22、ade in writing, to the AAMI Vice President, Standards Policy and Programs. An official interpretation must be approved by letter ballot of the originating committee and subsequently reviewed and approved by the AAMI Standards Board. The interpretation will become official and representation of the A

    23、ssociation only upon exhaustion of any appeals and upon publication of notice of interpretation in the “Standards Monitor“ section of the AAMI News. The Association for the Advancement of Medical Instrumentation disclaims responsibility for any characterization or explanation of a standard or recomm

    24、ended practice which has not been developed and communicated in accordance with this procedure and which is not published, by appropriate notice, as an official interpretation in the AAMI News. American National Standard ANSI/AAMI/ISO 5840-3:2013 Cardiovascular implants Cardiac valve prostheses Part

    25、 3: Heart valve substitutes implanted by transcatheter techniques Approved 23 November 2012 by Association for the Advancement of Medical Instrumentation Approved 4 December 2012 by American National Standards Institute Abstract: Outlines an approach for verifying/validating the design and manufactu

    26、re of a transcatheter heart valve substitute through risk management. The selection of appropriate verification/validation tests and methods are to be derived from the risk assessment. The tests may include those to assess the physical, chemical, biological and mechanical properties of heart valve s

    27、ubstitutes and of their materials and components. The tests can also include those for preclinical in vivo evaluation and clinical evaluation of the finished heart valve substitute. Keywords: design, hydrodynamic, material, performance, preclinical, risk, verification, structural AAMI Standard This

    28、Association for the Advancement of Medical Instrumentation (AAMI) standard implies a consensus of those substantially concerned with its scope and provisions. The existence of an AAMI standard does not in any respect preclude anyone, whether they have approved the standard or not, from manufacturing

    29、, marketing, purchasing, or using products, processes, or procedures not conforming to the standard. AAMI standards are subject to periodic review, and users are cautioned to obtain the latest editions. CAUTION NOTICE: This AAMI standard may be revised or withdrawn at any time. AAMI procedures requi

    30、re that action be taken to reaffirm, revise, or withdraw this standard no later than 5 years from the date of publication. Interested parties may obtain current information on all AAMI standards by calling or writing AAMI, or by visiting the AAMI website at HUwww.aami.orgUH. All AAMI standards, reco

    31、mmended practices, technical information reports, and other types of technical documents developed by AAMI are voluntary, and their application is solely within the discretion and professional judgment of the user of the document. Occasionally, voluntary technical documents are adopted by government

    32、 regulatory agencies or procurement authorities, in which case the adopting agency is responsible for enforcement of its rules and regulations. Published by Association for the Advancement of Medical Instrumentation 4301 N. Fairfax Drive, Suite 301 Arlington, VA 22203-1633 HUwww.aami.orgUH 2013 by t

    33、he Association for the Advancement of Medical Instrumentation All Rights Reserved This publication is subject to copyright claims of ISO, ANSI, and AAMI. No part of this publication may be reproduced or distributed in any form, including an electronic retrieval system, without the prior written perm

    34、ission of AAMI. All requests pertaining to this document should be submitted to AAMI. It is illegal under federal law (17 U.S.C. 101, et seq.) to make copies of all or any part of this document (whether internally or externally) without the prior written permission of the Association for the Advance

    35、ment of Medical Instrumentation. Violators risk legal action, including civil and criminal penalties, and damages of $100,000 per offense. For permission regarding the use of all or any part of this document, complete the reprint request form at HUwww.aami.orgUH or contact AAMI at 4301 N. Fairfax Dr

    36、ive, Suite 301, Arlington, VA 22203-1633. Phone: +1-703-525-4890; Fax: +1-703-525-1067. Printed in the United States of America ISBN 1-57020-492-6 Contents Page Glossary of equivalent standards vi Committee representation vii Background . vii Foreword . ix Introduction . x 1 Scope. 1 2 Normative ref

    37、erences 1 3 Terms and definitions 3 4 Abbreviations . 11 5 Fundamental requirements . 11 6 Device description . 11 6.1 Intended use . 11 6.2 Design inputs . 12 6.2.1 Operational specifications 12 6.2.2 Performance specifications 13 6.2.3 Implant procedure 15 6.2.4 Packaging, labeling and sterilizati

    38、on . 15 6.3 Design outputs . 15 6.4 Design transfer (manufacturing verification/validation) 15 6.5 Risk management 15 7 Design verification testing and analysis/design validation . 16 7.1 General requirements 16 7.2 In vitro assessment 16 7.2.1 Test conditions, sample selection and reporting require

    39、ments . 16 7.2.2 Material property assessment 17 7.2.3 Device hydrodynamic performance assessment . 18 7.2.4 Structural performance assessment 20 7.2.5 Additional implant design evaluation requirements 22 7.2.6 Delivery system design evaluation requirements 23 7.2.7 Design-specific testing 24 7.2.8

    40、Visibility 25 7.2.9 Simulated use . 25 7.2.10 Human factors/usability assessment . 25 7.3 Preclinical in vivo evaluation 25 7.3.1 Overall requirements . 25 7.3.2 Methods 27 7.3.3 Test report 28 7.4 Clinical investigations . 29 7.4.1 General 29 7.4.2 Statistical considerations . 29 7.4.3 Distribution

    41、 of subjects and investigators 30 7.4.4 Sample size . 30 7.4.5 Entry criteria . 30 7.4.6 Duration of the study . 30 7.4.7 Clinical data requirements 31 7.4.8 Clinical investigation report 33 Annexes Annex A (informative) Rationale for the provisions of this part of ISO 5840 35 Annex B (informative)

    42、Examples of transcatheter heart valve substitutes, components and delivery systems 38 Annex C (normative) Packaging . 44 Annex D (normative) Product labels, instructions for use and training 45 Annex E (normative) Sterilization . 49 Annex F (informative) Valve description . 50 Annex G (informative)

    43、Transcatheter heart valve substitute hazards, associated failure modes and evaluation methods . 52 Annex H (informative) In vitro test guidelines for paediatric devices 57 Annex I (informative) Statistical procedures when using performance criteria 62 Annex J (informative) Examples and definitions o

    44、f some physical and material properties of transcatheter heart valve substitutes and their components . 63 Annex K (informative) Examples of standards applicable to testing of materials and components of transcatheter heart valve substitutes . 78 Annex L (informative) Raw and post-conditioning mecha

    45、nical properties for support structure materials . 85 Annex M (informative) Corrosion assessment . 87 Annex N (informative) Guidelines for verification of hydrodynamic performance . 90 Annex O (informative) Durability testing . 94 Annex P (informative) Fatigue assessment 96 Annex Q (informative) Pre

    46、clinical in vivo evaluation . 103 Annex R (normative) Adverse event classification during clinical investigation . 106 Annex S (informative) Echocardiographic protocol . 112 Bibliography 115 Figures Figure 1 Schematic representation of flow waveform and regurgitant volumes for one cycle 4 Figure 2 S

    47、chematic representation of the positive pressure period of an aortic forward flow interval 9 Figure B.1 Example A . 38 Figure B.2 Example B . 39 Figure B.3 Example C . 39 Figure B.4 Example D . 40 Figure B.5 Example E . 40 Figure B.6 Example F . 41 Figure B.7 Example G 41 Figure B.8 Example H . 42 F

    48、igure B.9 Example I 42 Figure B.10 Example J . 43 Figure B.11 Example K. 43 Figure J.1 Example DSC graph for single-stage transformation nickel-titanium alloy . 72 Figure J.2 Typical stress-strain curve of superelastic (SE) nitinol indicating various reportable parameters . 74 Figure J.3 Force-diame

    49、ter curve of a superelastic (SE) nitinol support structure demonstrating chronic outward force (COF) and radial resistive force (RRF) 76 Figure P.1 Example schematic of a structural component fatigue assessment using a stress-or strain-life approach . 96 Tables Table 1 Heart valve substitute operational environment for left side of heart Adult population . 12 Table 2 Heart valve substitute operational environment for right side of heart Adult population . 13 Table 3 Minimum device performance requirements, aortic . 18 Table 4Minimum d


    注意事项

    本文(ANSI AAMI 5840-3-2013 Cardiovascular implants - Cardiac valve prostheses - Part 3 Heart valve substitutes implanted by transcatheter techniques.pdf)为本站会员(postpastor181)主动上传,麦多课文档分享仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文档分享(点击联系客服),我们立即给予删除!




    关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

    copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
    备案/许可证编号:苏ICP备17064731号-1 

    收起
    展开